SYK
$335.67-4.09 (-1.20%)
Stryker Corporation operates as a medical technology company.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endosco...
Recent News
Microsoft Security Concerns Rise After Cyberattack
U.S. flags risks in widely used enterprise tools
Stryker Investors Weigh Cyberattack Recovery As CEO Joins GE HealthCare Board
Stryker CEO Kevin Lobo has been appointed to the Board of Directors of GE HealthCare. The appointment links leadership at two large medical technology companies with global reach. Stryker, traded as NYSE:SYK, enters this leadership development with its shares at $345.81. Over the past 3 years the stock shows a total return of 30.7%, and over 5 years a total return of 55.7%, which gives investors some historical context for how the company has rewarded long term holders. For investors...
1 Oversold Stock Primed to Rebound and 2 We Question
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.
Investors have ignored healthcare as they have tried to capture earnings momentum in AI-related semiconductor stocks.
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Stryker rides on double-digit growth and robotics demand into 2026, but tariffs, vascular weakness and international hurdles cloud its near-term outlook.